COMMERCIAL EVALUATION AND LICENSE AGREEMENTCommercial Evaluation and License Agreement • July 12th, 2021 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl
This First Amendment to Commercial Evaluation and License Agreement (“First Amendment”) is effective as of the date of the last signature on the signature page between the UNIVERSITY OF MARYLAND, BALTIMORE (“University”), a public university that is part of the University System of Maryland (which is a public corporation and an instrumentality of the State of Maryland), and SILO PHARMA, INC., a Florida corporation (“Company”).
Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • July 12th, 2021 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl
This Sponsored Research Agreement (“Agreement”) is effective as of the last date of signature on the signature page below (“Effective Date”) by and between the University of Maryland, Baltimore (“UMB”), a public university of the State of Maryland, having offices at 620 West Lexington Street, 4th floor, Baltimore, Maryland 21201, and Silo Pharma, Inc., a Delaware corporation with its principal place of business at 560 Sylvan Ave, Suite 3160, Englewood Cliffs, New Jersey 078632( “Sponsor”).
